# Paolo Rossi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paolo-rossi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,699 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 32 |
| i10-index | 54 |
| Last Known Institution | Hillenbrand (United States) |
| OpenAlex ID | https://openalex.org/A5101810905 |
| ORCID iD | 0000-0002-8993-1068 |
| Works | 115 |

## Researcher papers

- [A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex<sup>®</sup>), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis](https://scholariq.org/papers/a-randomized-double-blind-placebo-controlled-parallel-group-enriched-design/)
- [Default-mode network dysfunction and cognitive impairment in progressive MS](https://scholariq.org/papers/default-mode-network-dysfunction-and-cognitive-impairment-in-progressive-ms/)
- [Physiopathology and treatment of fatigue in multiple sclerosis](https://scholariq.org/papers/physiopathology-and-treatment-of-fatigue-in-multiple-sclerosis/)
- [Fatigue in Multiple Sclerosis Is Associated with Abnormal Cortical Activation to Voluntary Movement—EEG Evidence](https://scholariq.org/papers/fatigue-in-multiple-sclerosis-is-associated-with-abnormal-cortical-activation-to/)
- [Real‐life impact of early interferonβ therapy in relapsing multiple sclerosis](https://scholariq.org/papers/real-life-impact-of-early-interferon-therapy-in-relapsing-multiple-sclerosis/)
- [Temporal dynamics in total excess mortality and COVID-19 deaths in Italian cities](https://scholariq.org/papers/temporal-dynamics-in-total-excess-mortality-and-covid-19-deaths-in-italian/)
- [MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatique](https://scholariq.org/papers/mri-and-motor-evoked-potential-findings-in-nondisabled-multiple-sclerosis/)
- [The DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis](https://scholariq.org/papers/the-dymus-questionnaire-for-the-assessment-of-dysphagia-in-multiple-sclerosis/)
- [Neurocognitive robot-assisted rehabilitation of hand function: a randomized control trial on motor recovery in subacute stroke](https://scholariq.org/papers/neurocognitive-robot-assisted-rehabilitation-of-hand-function-a-randomized/)
- [Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020](https://scholariq.org/papers/mortality-impacts-of-the-coronavirus-disease-covid-19-outbreak-by-sex-and-age/)
- [Neural correlates of laparoscopic training: a preliminary study](https://scholariq.org/papers/neural-correlates-of-laparoscopic-training-a-preliminary-study/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Stroke Rehabilitation and Recovery](https://scholariq.org/topics/stroke-rehabilitation-and-recovery/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Long-Term Effects of COVID-19](https://scholariq.org/topics/long-term-effects-of-covid-19/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Hillenbrand (United States)](https://scholariq.org/institutions/hillenbrand-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.